Johannes Streffer is Neurologist and Psychiatrist, currently VP, Head of Translational Medicine Neuroscience and Visiting Professor, Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Belgium. With his group he is focusing on creating an integrated translational space with clinical and biomarker sciences to support early development in support of discovery projects, thru first-in-human studies until proof-of-concept. For the biomarker aspects this continuing in the life cycle of our medicines. Johannes was trained in Tubingen (Neurology) and Zurich (Psychiatry). He joined the industry in 2007 at Janssen R&D (Pharmaceutical companies of Johnson & Johnson) and held roles of increasing responsibility, till he joined UCB Biopharm in his current role in 2017. He is Visiting Professor at the Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp and has co-lead EMIF-AD, an IMI PPP. Johannes has published more than 60 articles in peer reviewed journals, including Brain, Neuron, The Lancet and Nature Medicine.